🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07444099
Enrolling by invitation Not applicable

Early Postoperative Intervention in Gastric Cancer Patients

NCT07444099 · tracked via the Priya Life Science China tracker
Sponsor
Qilu Hospital of Shandong University
Phase
Not applicable
Started
2026-02-10
Last updated
2026-03-02

Condition(s) studied

Gastric Cancer (GC)Postoperative Recovery

Investigational drug(s) / intervention(s)

Early structured postoperative intervention encompassing nutrition, psychology, and exercise

Early structured postoperative intervention encompassing nutrition, psychology, and exercise: Nutritional intervention: Routine postoperative oral nutritional supplements (ONS) will be provided, and patients with metabolic diseases such as diabetes will undergo strict glycemic control. Psychological intervention: Patients with a Hospital Anxiety and Depression Scale (HADS) score ≥ 8 will receive cognitive behavioral therapy (CBT), and those with a HADS score ≥ 11 will be referred for psychological consultation. Exercise intervention: Postoperative rehabilitation training will be guided according to different postoperative periods.

Study summary

This study was conducted by Qilu Hospital and five other renowned medical centers, aiming to evaluate the impact of early structured postoperative intervention on quality of life and prognosis in patients with gastric cancer after neoadjuvant therapy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Age 18-80 years; * Histologically confirmed adenocarcinoma by preoperative pathology; * Completed preoperative neoadjuvant therapy without obvious immune-related adverse events (irAEs); * Patients with ycT3-4N+Mx disease deemed surgically resectable based on evaluation by gastroscopy, CT, PET-CT, and other imaging modalities; * Signed informed consent and voluntary participation in this study; * Standard ERAS (Enhanced Recovery After Surgery) management during the - perioperative period, with postoperative hospital stay ≤7 days. Exclusion Criteria: * Patients with central nervous system diseases or psychiatric disorders; * Patients with severe diseases of other organ systems; * Patients with recurrent infectious diseases or severe comorbidities; * Patients requiring synchronous surgery for other diseases; * Patients undergoing emergency surgery; * Patients who developed any complication during hospitalization.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Qilu Hospital of Shandong University Jinan Shandong

More Qilu Hospital of Shandong University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07444099 on ClinicalTrials.gov ↗ ← All trials in China